|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:category
|
gptkb:biotechnology
gptkb:company
Biotechnology company
|
|
gptkbp:CEO
|
gptkb:Ramy_Farid
|
|
gptkbp:collaboratesWith
|
gptkb:Pfizer
gptkb:AstraZeneca
gptkb:Sanofi
gptkb:Takeda_Pharmaceutical_Company
gptkb:Bristol_Myers_Squibb
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:founded
|
1990
|
|
gptkbp:founder
|
gptkb:Richard_A._Friesner
|
|
gptkbp:headquartersLocation
|
gptkb:New_York_City
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schrödinger, Inc.
|
|
gptkbp:industry
|
computational chemistry
drug discovery
|
|
gptkbp:IPODate
|
2020
|
|
gptkbp:notableAchievement
|
collaborated on COVID-19 drug discovery projects
pioneered FEP+ technology for drug discovery
|
|
gptkbp:numberOfEmployees
|
over 700
|
|
gptkbp:officeLocation
|
gptkb:Bangalore,_India
gptkb:Cambridge,_Massachusetts
gptkb:London,_United_Kingdom
gptkb:Munich,_Germany
gptkb:Portland,_Oregon
gptkb:San_Francisco,_California
gptkb:Tokyo,_Japan
gptkb:San_Diego,_California
|
|
gptkbp:product
|
gptkb:Jaguar
gptkb:Desmond
gptkb:Glide
gptkb:Epik
gptkb:FEP+_(Free_Energy_Perturbation)
gptkb:LiveDesign
gptkb:Maestro
Prime
Canvas
Phase
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:specializesIn
|
materials science
computational drug design
molecular modeling software
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:SDGR
|
|
gptkbp:subsidiary
|
gptkb:Schrödinger_GmbH
gptkb:Schrödinger_K.K.
|
|
gptkbp:website
|
https://www.schrodinger.com/
|
|
gptkbp:bfsParent
|
gptkb:John_M._Millam
gptkb:Scottish_Mortgage_Investment_Trust
|
|
gptkbp:bfsLayer
|
7
|